⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9873048 | 0.79 | — | — | |
| SCHEMBL2580163 | 0.78 | ALDH1A1 (0.59) | — | |
| SCHEMBL9440656 | 0.78 | ALDH1A1 (0.39) | — | |
| SCHEMBL11781459 | 0.78 | TSHR (0.36) | — | |
| SCHEMBL14613512 | 0.76 | — | — | |
| SCHEMBL29229760 | 0.76 | ALDH1A1 (0.41) | — | |
| SCHEMBL28307387 | 0.75 | MCL1 (0.38) | — | |
| SCHEMBL2576522 | 0.74 | TSHR (0.55) | — | |
| SCHEMBL22082472 | 0.74 | ALDH1A1 (0.35) | — | |
| SCHEMBL29178572 | 0.74 | ALDH1A1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100279900-A1 | SOLID SUPPORT COMPRISING A FUNCTIONALIZED ELECTRICITY CONDUCTOR OR SEMICONDUCTOR SURFACE, METHOD FOR PREPARING SAME AND USES THEREOF | COMMISSARIAT A L'ENERGIE ATOMIQUE | 2010-11-04 | — | — | US | claimed |
| US-20050272143-A1 | Solid support comprising a functionalized electricity conductor or semiconductor surface, method for preparing same and uses thereof | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2005-12-08 | — | — | US | claimed |
| EP-4288426-B1 | QUINOXALINE DERIVATIVES AND USES THEREOF | BLACK DIAMOND THERAPEUTICS INC (US) | 2026-02-04 | — | — | EP | disclosed |
| WO-2025226892-A1 | SPIROCYCLE-CONTAINING DIAMINOMETHYLENE PYRIMIDINE-2,4,6-TRIONE AGONISTS OF PARATHYROID HORMONE 1 AND INCRETIN RECEPTORS | SEPTERNA, INC. (US) | 2025-10-30 | — | — | WO | disclosed |
| WO-2025226510-A1 | LPAR1 INHIBITORS | ABBVIE INC. (US) | 2025-10-30 | — | — | WO | disclosed |
| EP-4640274-A1 | LPAR1 INHIBITORS | AbbVie Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| US-20240368181-A1 | QUINOXALINE DERIVATIVES AND USES THEREOF | BLACK DIAMOND THERAPEUTICS, INC. (US) | 2024-11-07 | — | — | US | disclosed |
| EP-4288426-A1 | QUINOXALINE DERIVATIVES AND USES THEREOF | Black Diamond Therapeutics, Inc. (US) | 2023-12-13 | — | — | EP | disclosed |
| CN-117203202-A | Quinoxaline derivative and use thereof | 黑钻治疗公司 | 2023-12-08 | — | — | CN | disclosed |
| WO-2022170122-A1 | QUINOXALINE DERIVATIVES AND USES THEREOF | BLACK DIAMOND THERAPEUTICS, INC. (US) | 2022-08-11 | — | — | WO | disclosed |
| CN-114729076-A | Non-thiol nitrogen-based hydrophobic polymer brush materials and their use for substrate surface modification | 默克专利股份有限公司 | 2022-07-08 | — | — | CN | disclosed |
| US-6139819-A | COMPRISING LIPID, PROTEIN, POLYMER AND/OR SURFACTANT, AND A GAS, IN COMBINATION WITH A TARGETING LIGAND; TARGETING LIGAND TARGETS COAGULA, INCLUDING EMBOLI AND/OR THROMBI, PARTICULARLY IN PATIENTS SUFFERING FROM ARRHYTHMIC DISORDER | IMARX PHARMACEUTICAL CORP. (US) | 2000-10-31 | — | — | US | disclosed |
| WO-2000045856-A2 | NOVEL METHODS OF IMAGING AND TREATMENT WITH TARGETED COMPOSITIONS | IMARX PHARMACEUTICAL CORP. (US) | 2000-08-10 | — | — | WO | disclosed |
| WO-2000043050-A1 | MEDICAL ADHESIVES | ST. JUDE MEDICAL, INC. (US) | 2000-07-27 | — | — | WO | disclosed |
| EP-0831932-A4 | NOVEL TARGETED COMPOSITIONS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP (US) | 2000-01-12 | — | — | EP | disclosed |
| EP-0959908-A1 | NOVEL TARGETED CONTRAST AGENTS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1999-12-01 | — | — | EP | disclosed |
| WO-1999013919-A1 | NOVEL TARGETED CONTRAST AGENTS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1999-03-25 | — | — | WO | disclosed |
| EP-0831932-A1 | NOVEL TARGETED COMPOSITIONS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1998-04-01 | — | — | EP | disclosed |
| WO-1996040285-A1 | NOVEL TARGETED COMPOSITIONS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1996-12-19 | — | — | WO | disclosed |
| US-4032597-A | GRAFT POLYMER OF AN ACRYLONITRILE AND AN ACRYLIC ESTER | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-06-28 | — | — | US | disclosed |